The anti-obesity drug semaglutide may lower the risk of death from COVID-19, cardiovascular disease, and all causes, according to a randomized controlled trial published late last week in the Journal of the American College of Cardiology ( JACC )
doi: 10.1007/s11095-022-03302-1
Microdosing operates below the studied initiation threshold
Michelle 42lbs I am happier, healthier, and have made lifestyle changes that I know I will stick with
Recommendations for Starting and Maintaining a Semaglutide Regimen Semaglutide is typically prescribed as a once-weekly injection, taken with or without food
Despite these findings, there remains a lack of longitudinal or interventional studies specifically investigating the dynamic interaction between psychological burden and hormonal dysregulation in this population